NCM Boston | Oxford Nanopore Technologies
NCM Boston
NCM Boston
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
Oxford Nanopore Technologies
Michael Dean
)
- Job title
- Institution
- National Cancer Institute, USA
- Biography
Michael Dean is a senior investigator in the Laboratory of Translational Genomics. He obtained his PhD from the Biochemistry Department at the Boston University School of Medicine. He performed his postdoctoral studies at the National Cancer Institute, Center for Cancer Research (CCR), on the MET oncogene and cystic fibrosis gene. He is a member of the American Society of Human Genetics, the American Association of Cancer Research, and the Human Genome Organization (HUGO), and is an adjunct faculty member at Hood College. In 2022, Dr. Dean received the Hubert H. Humphrey Award for Service to America.
- Recent publications
Ayse, K. et al. Severus: accurate detection and characterization of somatic structural variation in tumor genomes using long reads. medRxiv 2024.03.22.24304756 (2024).
DOI: 10.1101/2024.03.22.24304756Rodriguez, I. et al. Insights into the mechanisms and structure of breakage-fusion-bridge cycles in cervical cancer using long-read sequencing. Am J Hum Genet. 111(3):544–561 (2024).
DOI: 10.1016/j.ajhg.2024.01.002